BGI-Shenzhen has again extended the deadline for its tender offer to acquire Complete Genomics (GNOM +1.6%), a move that comes in response to Illumina's (ILMN +0.8%) recently disclosed competing bid earlier this month that was rejected by the life sciences company. BGI's tender offer now expires on December 14.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs